At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 500 enrolled
Drug / intervention
everolimus eluting stent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Comparison of Everolimus Eluting Stents and Sirolimus Eluting Stent in Patients With ST Elevation Myocardial Infarction (STEMI) (RaCES-MI Trial)
In Brief
A Phase 4 clinical trial evaluating everolimus eluting stent and sirolimus eluting stent for Acute Myocardial Infarction. Completed, enrolled 500 participants across 1 site.
Detailed Summary
Randomized trial to test the efficacy and safety of newer Drug Eluting Stent generation in patient with acute myocardial infarction treated with primary percutaneous coronary intervention (PCI)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myocardial Infarction
CountriesItaly
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
Primary CompletionJun 2012
First PostedSep 2012
TodayJul 2026
First PostedSep 13, 2012
Enrollment StartApr 1, 2007
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 13.8 years ago
Interventions
everolimus eluting stentdevice
experimental arm of a comparison between drug eluting stents
sirolimus eluting stentdevice
control arm of a comparison between drug eluting stents